eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese

Areti Triantafyllou, Athina Pyrpasopoulou, Panagiota Anyfanti, Ekaterini Balaska, Spyros Aslanidis, Stella Douma
2013 Annals of the Rheumatic Diseases  
doi:10.1136/annrheumdis-2013-203240 pmid:23396663 fatcat:akto4lvvoffxpefprriaioky74